Simon Fraser University
Engaging the World

The Chan Zuckerberg Initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. The Patient-Partnered Collaborations for Rare Neurodegenerative Disease RFA aims to advance the understanding of the pathophysiology and mechanistic underpinnings of rare neurodegenerative and neurological disorders.

The Chan Zuckerberg Initiative invites applications from collaborative teams bringing together patient-led rare disease organizations and research teams for 4-year research projects aimed at advancing our understanding of the fundamental science of rare diseases. The Patient-Partnered Collaborations for Single-Cell Analysis of Rare Inflammatory Pediatric Disease RFA aims to support the application of single-cell biology methods to rare inflammatory pediatric diseases that will clarify cellular mechanisms of disease, understand disease heterogeneity, and improve biomarker identification or diagnostics.

Recognizes substantial recent contributions in the biomedical sciences.

Recognizes excellence in Canadian innovation and entrepreneurship, while educating present and future generations of disruptors.

Identifies and supports eminent women in science throughout the world.

For contributions to a field of basic or clinical research in one of the Institute's principal areas of research.

Brain Canada, the Canadian Stroke Consortium, and Heart &Stroke are pleased to launch the 2022 Stroke Clinical Research Catalyst Grant program. This funding opportunity will provide seed funding to develop new lines of research and generate preliminary data that would support successful applications to larger grants from granting agencies, while broadening the researcher’s clinical research program. Please see the funding opportunity link for more information.

The 2021 Federal Budget announced funding for CIHR's Clinical Trials Fund (CTF), an integral component of Canada's Biomanufacturing and Life Sciences Strategy (BLSS). In support of this, the CTF will provide funding through three specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of a broad spectrum of clinical trial initiatives. The CTF will support research and researchers across the country to conduct the full spectrum of clinical trials including the development and testing of new drugs, treatments, and public health and health system interventions to prevent, detect, treat, or manage various diseases or medical conditions.

Engages the broad public in informed discourse on matters related but not limited to health research and health research policy.

Recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science.

Recognizes a British Columbian clinician scientist whose work in health research is internationally recognized and has had a significant impact on advancing research in his or her field.

Celebrates and honours those in our B.C. community who successfully position our province as a competitive global cluster in the life sciences sector.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

Parkinson's Digital Health Application Grant: The intent of this grant is to fund the enhancement and evaluation of a digital health app that will engage people living with Parkinson's and support their approach to wellness by offering education, and wellness tracking metrics to empower them to optimize their health.

Recognizes outstanding contributions to medicine and the health sciences that have led to extraordinary improvements in human health.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. These grants further advance/translate projects with proof of concept and protected IP.

Recognizes individuals who have made, and are making, valuable contributions to cancer research and cancer control in Canada.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer.

CIHR-IG is partnering with the Fonds de recherche du Québec – Santé (FRQS), Ataxia Canada and approximately 26 international funding organizations in the context of this European Joint Programme on Rare Diseases (EJP RD) call for proposals 2022. CIHR-IG is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across Canada and the European Community (EC) to collaborate for better health outcome for the rare disease patient community. The topic of the call is Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

NSERC is re-launching a pilot funding opportunity to support investigator-initiated individual and team projects that broadly integrate or transcend disciplines to advance knowledge in the natural sciences and engineering (NSE). The Discovery Horizons grants are expected to be valued from $50K to $100K per year and NSERC is expecting to award approximately 10-20 grants for this pilot year. LOI application is due June 16, 2022 and invited applications are due by October 18, 2022. Kindly click on the funding opportunity link for more details.

Release time awards for active Canadian scholars who have made a significant and remarkable contribution to their respective fields in the humanities, social sciences, natural sciences, health sciences or engineering.

Recognizes remarkable individuals whose research or contributions to public policies supportive of research and development in Canada have achieved international recognition.

Research Teams are invited to submit Concept Notes for two-year research projects. Teams successful at the Concept Note stage will be invited to submit Full Proposals. The following types of research are considered in scope: Epidemiological studies that describe and analyze patterns of diseases or health among women and consider different population and occupational factors. Population health research that explores diverse women’s experiences as individuals and within the society (e.g., family and community, intergenerational relationships, socioeconomic groups, work groups and enterprises). Intervention and Implementation research focused on exploring how policies, practices and strategies already put in place to alleviate the impact of COVID-19 influence the relationships between women’s paid and unpaid work and their health.

Recognizes and encourages world-class research and artistic creation, prizing contributions of lasting impact for their originality, theoretical significance and ability to push back the frontiers of the known world.

Recognizes Canada’s leaders in sustainability for their contributions over the prior two years.

Honours a living person who has made an exceptional contribution to affirming life’s spiritual dimension, whether through insight, discovery, or practical works. 

In this Request for Proposals, the Canadian Glycomics Network (GlycoNet) is seeking to fund Clinical Partnership projects that would offer clinicians and biomedical researchers opportunities to partner with Network Investigators to study glycans or glycosylation changes in disease. This partnership would increase clinician awareness of the role of glycomics in disease, and expand glycomics translational research and its application in more problems of clinical importance. Partnership outcomes could be better understanding of disease, drug development strategies, or new drug targets.

Awards honouring contributions to the science of toxicology in Canada.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

MITACS Elevate is a fellowship available to postdocs in all disciplines, which can provide critical career and skills training to postdoctoral fellows through real-world collaborations. Postdoctoral fellows can apply for two years of funding valued at $80,000/year. For Spring 2022 Thematic Call, sector-specific experts in agriculture and food, artificial intelligence, biomanufacturing, clean technology, entertainment and media, quantum science, or social innovation. Key dates: • Call Launch is May 4th, 2022 • Internal university deadline is June 30, 2022 at 5pm PT • Application submission deadline to MITACS is July 6, 2022 at 5pm PT

The Healthy Cities Implementation Science (HCIS) Team Grants funding opportunity is offering grants focused on increasing our understanding of how to design, implement and promote the systematic and equitable uptake of evidence-based interventions (i.e. interventions that have been piloted or tested in a setting and found to be promising) in multiple urban environments to improve population health and well-being.

The Team Grants in Diabetes Prevention and Treatment in Indigenous Communities: Resilience and Wellness will support Indigenous-led and community-driven research that aims to reverse the upward trajectory of diabetes and associated co-morbidities (e.g. cardiometabolic disease) among First Nations, Inuit and Métis Peoples and their communities. The objective of this component is to define and integrate models of resilience and wellness into diabetes prevention and treatment approaches among First Nations, Inuit and Métis Peoples.

The 2021 Federal Budget announced funding for CIHR's Clinical Trials Fund (CTF), an integral component of Canada's Biomanufacturing and Life Sciences Strategy (BLSS). In support of this, the CTF will provide funding through three specific vehicles: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and, projects through the funding of a broad spectrum of clinical trial initiatives. The CTF will support research and researchers across the country to conduct the full spectrum of clinical trials including the development and testing of new drugs, treatments, and public health and health system interventions to prevent, detect, treat, or manage various diseases or medical conditions.

Recognizes those with a demonstrated track record in research with excellence in scientific rigor, innovative thinking, imagination and originality.

Recognizes mid-career investigators who have produced exceptional scientific research contributions with continued potential for impact on human health

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research

Recognizes an individual, team or organization that has advanced the mobilization of research in aging at a local or regional level.

In addition to recognizing faculty members for their contributions, the award funds bold and potentially game-changing projects that will challenge the status quo, spark change and take action to address persistent systemic barriers in the research ecosystem and academia.

Recognizes distinguished Chinese Canadians who have made outstanding professional achievements.

Rewards recent discoveries of particular originality and importance to basic medical research.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer. These grants further advance/translate projects with proof of concept and protected IP.

Empowers young researchers to lead International, interdisciplinary, and intergenerational dialogue with the goal to make global decision making evidence-based and inclusive.

Stimulates fundamental research by early-career scientists and scholars of outstanding promise.

The Canadian Glycomics Network (GlycoNet) is a Network of Centres of Excellence that focuses on the role of glycans (carbohydrates) in health. Areas of focus are neurodegenerative diseases, infectious diseases, chronic diseases, in particular diabetes & obesity, genetic diseases involving errors in glycan metabolism, and cancer.

Sony Corporation of America is accepting applications for two Research Award Programs: Faculty Innovation Award and Focused Research Award. Proposal submissions are open from July 15, 2021 to September 15, 2021. This Program is intended to foster partnership with university faculty and researchers. It will support university research and innovation in the U.S. and Canada (plus India and select countries in Europe) with awards of up to $150,000 USD per year for each accepted proposal.

The Stem Cell Network is pleased to launch a new multimillion-dollar national research funding competition to support world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians. This new competition will open Wednesday, September 1, 2021 and support research activities during the 2022-2025 time period. Seven regenerative medicine research programs will be available that focus on career development, innovation, clinical translation, policy and societal impact, commercialization and transformative technology development. A LOI submission is required for all SCN funding programs. LOIs are due September 22, 2021 and full application deadline is December 1, 2021. Please click on the link above for more information about the seven new SCN funding programs.

A self-governing Fellowship made up of the most eminent scientists, engineers and technologists from the UK and the Commonwealth.

Aims to provide fresh impetus to first-class research and development in the 21st century, to bring about positive change to the global community, and to create a brighter future for all humanity.

Recognizes breakthroughs in pure or applied life science research.

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research

Recognizes the world's top scientists who have made outstanding achievements in Global Health Research.

Recognizes outstanding biomedical scientists who have made original contributions to medicine.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

National Heart, Lung, and Blood Institute (NHLBI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

The Canadian Space Agency (CSA) is interested in human spaceflight and maintaining a healthy and highly qualified Canadian astronaut corps capable of participating in space exploration missions. The intent of this Announcement of Opportunity (AO) is to provide financial support to researchers in Canadian Universities, post-secondary institutions, and not for profit organizations to conduct science investigations that will lead to a better understanding of human spaceflight risks while contributing to improve remote medicine and health benefits here on Earth. Deadline to apply is October 7, 2022 at 2:00 PM (EST).

Honours excellence in health research and its translation into benefits for Canadians.

Rewards outstanding achievement in the fields of: Biochemistry and Biophysics, Cognitive Science, Environmental Sciences, History, and Medicine

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

NSERC is re-launching a pilot funding opportunity to support investigator-initiated individual and team projects that broadly integrate or transcend disciplines to advance knowledge in the natural sciences and engineering (NSE). The Discovery Horizons grants are expected to be valued from $50K to $100K per year and NSERC is expecting to award approximately 10-20 grants for this pilot year. LOI application is due June 16, 2022 and invited applications are due by October 18, 2022. Kindly click on the funding opportunity link for more details.

Recognizes renowned scientists and artists for their achievements for humanity and for friendly relations between people.

The 2022 CIFAR Azrieli Global Scholars program is now open. The CIFAR Azrieli Global Scholars program supports exceptional early-career researchers with an interdisciplinary, global network, mentorship, leadership development and $100,000 in unrestricted research support. Applications must be received by October 27, 2021 at 11:59 PM (PST. Please click on the link above for more information.

Recognizes the world’s most foremost scientists, physicians and researchers for their breakthroughs in bio-medicine.

Recognizes individuals who have made, and are making, valuable contributions to cancer research and cancer control in Canada.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

For new research collaborations jointly developed by French and Canadian teams that have never worked together before.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Recognizes exceptional contributions in the area of population and public health research.

Recognizes current or recent innovations that have a positive impact on the quality of life in Canada.

Recognizes and encourages innovative and interdisciplinary research that cuts across traditional boundaries and paradigms.

Honours individuals who have recently achieved significant breakthrough in academic and scientific research or applications.

NSERC has announced a new grants program called Alliance Mission Grants. This program is aimed at addressing critical science and technology challenges that can play a pivotal role in Canada's economy. Alliance Mission grants will provide $100,000 to $500,000 per year for two years, to initiate research collaborations between Canada's academic researchers and partners from private, public, and/or not-for-profit organization(s). These grants will cover 100% of the eligible costs of researcher for a two-year period. Project proposals should be focused on addressing challenges that have emerged as a result of the pandemic and/or respond to new economic opportunities. Applicants must be eligible to hold NSERC funds and must hold at least one active peer-reviewed grant from NSERC. Deadline to apply is November 30, 2021 at 5:00p.m. (PST).

A one-year grant of up to $30,000 for innovative health and biomedical research projects by outstanding new investigators at universities and research institutes in Canada, who are within the first three years of their first academic appointment and who have received less than $200,000 as part of their start-up package

Recognizes remarkable contributions in the arts, the humanities and the sciences, as well as in Canadian public life.

Recognizes the emerging generation of Canadian intellectual leadership.

Within its objective under the Canadian Institutes of Health Research Act, CIHR is charged with addressing emerging health challenges. CIHR is also positioned, as Canada's federal funding agency for health research, to provide focused public funding for emerging health challenges. Against this backdrop, and recognizing a need for independent research on cannabis health issues, CIHR is launching a funding opportunity for research projects. This current funding opportunity is comprised of two components: Existing Longitudinal Studies and a New Longitudinal Study on Cannabis Use in Veterans.

Celebrates the contributions of individuals who have had a remarkable impact on cancer research and the cancer research community.

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias. NOTE: This funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. We have dedicated our funding to several key areas: - Translational research to develop new drugs and build preclinical evidence - IND-enabling studies and early-stage clinical trials for novel and repurposed drugs - Development and validation of plasma, CSF, neuroimaging and digital biomarkers - Epidemiological studies and comparative effectiveness research

Honours extraordinary women leaders.

The MSFHR Scholar Program supports early-career health researchers who are building leading-edge health research programs, training the next generation of scientists and expanding their potential to make significant contributions to their field.

Honours individuals in the fields of Cosmology, Genetics, and Neuroscience, whose groundbreaking work provides new models that inspire and enable fundamental shifts in knowledge and culture.

The Government of Canada has announced special funding, in the form of supplements to existing research grants, that will provide relief and assistance to research trainees from Ukraine. The Special Response Fund for Trainees (Ukraine) is administered by Canada’s three federal research funding agencies – CIHR, NSERC and SSHRC – and provides support to graduate students and postdoctoral researchers directly impacted by the Russian regime’s invasion of Ukraine. Applications will be accepted using a continuous intake up to December 22, 2022.

Recognizes outstanding achievement, dedication to the community and service to the nation.

Recognizes excellence in astronomy and mathematics, biosciences, geosciences or polyarthritis research.

Recognizes individuals and organizations who have demonstrated exceptional leadership, integrity, respect and commitment to furthering Reconciliation or inspiring others to continue Reconciliation efforts.

Promotes originality and excellence of research in the field of Biophysics.

Recognizes researchers in the area of psychiatry who are making an outstanding contribution in the field.

The goal of the Transitions in Care (TiC) CIHR multi-Institute initiative is to improve the health and well-being of all peoples in Canada by supporting research that transforms the health system to optimize the outcomes of patients experiencing transitions in care. Since the launch of the initiative in 2018, 53 projects have been funded across Canada using a number of different funding mechanisms. The focus of this funding opportunity is to support inter-disciplinary teams that are poised and ready to optimize health outcomes during transitions in care. The grants will provide support to co-develop, implement, evaluate, and equitably spread and/or scale (share) pragmatic solutions to challenges associated with transitions in care from a clinical, health care or health system perspective.

Celebrates British Columbians who go above and beyond in their dedication and service to others and who devote time and energy to making their communities more caring, dynamic, beautiful, healthy, and unique.

Awards service to humanity in the fields of physics, chemistry, physiology or medicine, literature, and peace.

Recognizes significant contributions to the advancement of science and technology.

Recognizes the contributions of scientists, physicians, and public servants who have made major advances in the understanding, diagnosis, treatment, and prevention of human disease.

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

Recognizes a Canadian physician or scientist who makes outstanding contributions to the treatment, amelioration, or development of therapies for cancer.

Recognizes outstanding contributions to the treatment, amelioration, or cure of brain disorders.

Recognizes outstanding contributions to the treatment, amelioration, or cure of heart disorders.

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Rewards excellence by recognizing breakthroughs in science and technology.

Recognizes contributions to the theoretical foundations of human cognition.

For outstanding achievements in research of any branch of science.

Recognizes contributions to the understanding of vision loss.

Honours and supports those offering practical and exemplary answers to the most urgent challenges facing us today.

The Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH.Standard due dates for new applications are February 5, June 5, and October 5.

Recognizes the outstanding and creative achievements of researchers in the fields of medicine and life sciences, in particular those contributing to scientific developments in medicine.

Recognizes contributions to the promotion of health science.

Honours scientists who have made significant contributions in Paul Ehrlich's field of research, in particular immunology, cancer research, microbiology, and chemotherapy.

Awards outstanding scientific contributions of individuals from all scholarly disciplines aiming at improving the development and living conditions of children and youth.

Fosters culture, the sciences and the most meritorious initiatives in the cause of humanity, peace and fraternity among peoples throughout the world. 

The R21 grant mechanism is intended to encourage exploratory/developmental research by providing support for the early and conceptual stages of project development. Standard due dates are February 16, June 16, and October 16.

Recognizes outstanding works in five categories: Service to Islam, Islamic Studies, Arabic Language and Literature, Medicine, and Science.

Recognizes an important publication in the history of medicine.

Recognizes scientific contributions relating to tobacco consumption and disease.

Recognizes excellence in medical science.

The Natural Sciences and Engineering Research Council of Canada (NSERC) is pleased to remind the community of an important funding opportunity for Canadian researchers interested in ambitious, international projects in the life sciences. Human Frontier Science Program (HFSP) Research Grants support innovative basic research into fundamental biological problems with emphasis placed on novel and interdisciplinary approaches that involve scientific exchanges across national and disciplinary boundaries. Please see the funding opportunity link for more information.

Recognizes individuals who have made profound contributions in Fundamental Physics, Life Sciences and Mathematics.

Honours outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators.

Any British Columbian (or former long-term resident) who has demonstrated outstanding achievement, excellence or distinction in any field. Community leadership, business, labour, industry, volunteer service, research, culture, the arts, sports… the possibilities are nearly endless.

Honours champions in health research advocacy.

The Michael Smith Health Research BC Health Professional-Investigator Program helps close the gap between health research and its implementation. The purpose of the Health Research BC Health Professional-Investigator (HP-I) program is to support health professionals who are actively involved in patient care to conduct and apply research relevant to health and the health system, with the aim of closing the gap between health research and its implementation. Please see the funding opportunity link for more information.

SRCFC Major Grants support biomedical research into Solving the Puzzles of the Mind. The focus of the research should be on the causes and cure of the disease as opposed to the active treatment or palliative care.

SRCFC Major Grants support biomedical research into Solving the Puzzles of the Mind. The focus of the research should be on the causes and cure of the disease as opposed to the active treatment or palliative care.

Canada’s International Development Research Centre (IDRC) and the Canadian Institutes of Health Research’s Institute of Population and Public Health (CIHR-IPPH) are pleased to announce a new funding opportunity to identify and implement effective knowledge mobilization strategies to integrate the Canadian Coalition for Global Health Research’s (CCGHR) Principles for Global Health Research (known hereafter as the Principles) across the global health research ecosystem. Please see the funding opportunity link for more information.

Island Health seeking a new Research Scholar in Residence to collaborate with our Mental Health and Substance Use Team to support health-based research (two-year term). See full competition posting on the link above

Honours sustained excellence in Canadian health care and/or health care research.

Rewards an individual who has promoted sound science and evidence on a matter of public interest.

The William and Ada Isabelle Steel Fund reflects the intent of the endowment left by William and Ada Isabelle Steel for research studies into any aspect of alcoholism and/or drug addiction. Submissions are accepted April 18 through May 18.

The Canada Biomedical Research Fund (CBRF) is an institutional program administered by the Tri-agency Institutional Programs Secretariat (TIPS) housed at Social Sciences and Humanities Research Council (SSHRC) on behalf of the three federal research funding agencies: the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC) and SSHRC. The CBRF is based on an ecosystem approach and is designed to build on existing assets, infrastructure, partnerships, and strengths of institutions and to support targeted investments for maximum impact. The total budget for CBRF is $250 million over four years starting in 2022-2023.

Brain Canada is partnering with the Quantum Leap pharma-led funding program for drug discovery research on eligible brain related project. Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Please see the funding opportunity link for more information.

The Alzheimer’s Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) jointly announce that the Accelerating Drug Discovery for Frontotemporal Degeneration RFP is now accepting letters of intent. This RFP supports innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy) drug development programs for frontotemporal dementia (FTD).

Recognizes scientists for pioneering advances in our understanding of existence at its biggest, smallest, and most complex scales. 

Recognizes an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.

The Project Grant program is designed to capture ideas with the greatest potential for important advances in fundamental or applied health-related knowledge, health care, health systems, and/or health outcomes by supporting projects of research proposed and conducted by individual researchers or groups of researchers in all areas of health. The best ideas may stem from new, incremental, innovative, and/or high-risk lines of inquiry or knowledge translation approaches.

SRCFC Major Grants support biomedical research into Solving the Puzzles of the Mind. The focus of the research should be on the causes and cure of the disease as opposed to the active treatment or palliative care.

To improve the treatment, quality of life, and long-term outlook for children with brain tumors through research, support, education, and advocacy.

An Investigator Award supports individuals who are 4‐10 years into their careers as investigators and have made outstanding contributions and demonstrated leadership in arthritis research.

These grants provide support for meetings that promote the development of new research teams, for grant planning specifically for arthritis

Provides one-time funding to catalyze research in models of care in preparation for larger scale competitions to be offered by the Society and other funding agencies.

Funding to support research proposals aligned with the Society’s priorities.

To assist young investigators with laboratory start up costs. These grants can be combined with institutional, provincial or other eligible matching funds to purchase major equipment.

Intended to provide junior academics within 4 years of a full time research appointment, with what would usually be their first opportunity to demonstrate their ability to initiate and carry out independent research of relevance to arthritis.

The Alliance for Accelerating Excellence in Science in Africa (AESA), an initiative of the African Academy of Sciences and the New Partnership for African Development (NEPAD), in partnership with the Bill & Melinda Gates Foundation has launched two requests for proposals for Grand Challenges Africa - Innovation Seed Grants

A Brain Tumour Research Fellowship encourages and enables young clinicians and scientists to enter the field of brain tumour research and will accelerate studies leading to a cure for brain tumours.

CCS-Partner Prevention Research Grants have been created to support investigators who approach research in key prevention and risk reduction areas.

To encourage research projects that will close the gap between what is known from research and what is done with that knowledge in the health care community and public health practice.

To support and accelerate research and the application of new knowledge with imminent application potential relevant to cancer prevention in human populations.

This program funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data used to qualify for larger, more sustained grants from other organizations.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer.

The overarching goal of the Ovarian Cancer Academy is to develop successful, highly productive ovarian cancer researchers in a collaborative research and career development environment.

To support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Currently no program funding opportunities are open.

By coupling research and innovation, Horizon 2020 emphasizes excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.

The programme supports research and study visits up to three months within the framework of the bilateral exchange of scientists and scholars.

Supports eligible recipients to pursue targeted R&D partnerships with key foreign organizations that may lead to the commercialization of Canadian technologies.

Grand Challenges Canada seeks bold ideas for products, services and implementation models that could transform how persistent challenges in reproductive, maternal, newborn and child health are addressed in low- and middle-income countries.

Funding for investigation and support of complementary and alternative medicine and for economic education that promotes the principles of a free market.

The objectives of the IC-IMPACTS Innovation Demonstration Initiative are to encourage the transfer of technology and knowledge resulting from India-Canada research and technology development partnerships, foster Canada-India collaborative research and trade development activities, demonstrate the effectiveness of innovative technologies for the Canadian and Indian marketplace, and improve the health, safety and prosperity of communities through the introduction of new technologies in Canada and/or India and to improve Canada-India economic ties.

A variety of targeted research grants related to understanding and curing diabetes, launched on an ongoing basis.

The Canadian Lung Association funds research and research training at the national level, offering several competitions for research funding.

The mission of the March of Dimes is to improve the health of babies by preventing birth defects, premature birth and infant mortality.

To initiate interdisciplinary discussions on problems or issues, to help launch interdisciplinary research networks, or to fund communities of researchers/practitioners dedicated to developing new methods, tools, and applications of basic research to applied problems.

Build research partnerships while funding your grad students and postdocs. Apply any time for flexible funding.

A pilot program to grow small to medium enterprises and other companies in Canada by connecting them with multinational sponsor companies and talented researchers at Canadian universities to collaborate on industrial research challenges of mutual interest.

This program supports graduate student research in a 16 to 24 week research project with an international industry partner located in any country except the United States.

NIH offers funding for many types of grants and contracts.

The US National Science Foundation funds research and education in most fields of science and engineering.

Prostate Cancer Canada offers a limited number of Discovery Grants. While supporting novel research that aims to open up new lines of investigation, the goal is to support new and innovative studies in prostate cancer research.

Prostate Cancer Canada invites applications for investigator-initiated Movember Translation Acceleration Grants that address a significant issue in the management of prostate cancer. Proposals should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember initiatives.

The mission of the Simons Foundation Autism Research Initiative is to improve the understanding, diagnosis and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.

Aimed at researchers who want to host their own scientific event in Switzerland, invite colleagues from abroad for a research visit to Switzerland, or visit their colleagues in another country.

Research grants for children's medical research.

Small grants

Awarding educational and research grants to recipients who have become the world’s leading scientists and voice clinicians.

This award would be suitable for spending a sabbatical year in Germany. An academic in Germany with whom you would collaborate during your sabbatical could nominate you for this award.

Grants to outstanding Canadian charitable organizations offering unique and inspiring programs or projects for the benefit, improvement and development of Canadian society.

To carry out long-term research (6-24 months) in Germany. Applicants choose their own topic of research and their academic host.

To sponsor a 6 to 18 month research stay at a research institution in Germany. The fellowship is flexible and can be divided up into as many as three stays within three years.

Scientists and scholars from all non-European countries, who completed their doctorates less than 18 years ago, who are internationally recognized for their achievements in the field of applied research, and who in future are expected to continue producing cutting-edge achievements which will have a seminal influence on their discipline beyond their immediate field of work, are eligible to be nominated for a Fraunhofer-Bessel Research Award.

Academics of all disciplines from abroad, who are internationally recognized as leaders in their field and who are expected to contribute to enhancing Germany's sustained international competitiveness as a research location in consequence of the award, are eligible to be nominated for an Alexander von Humboldt Professorship.

Granted in recognition of a researcher's entire achievements to date, to academics whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future.

Excellent scientists and scholars of all nationalities who are expected to continue producing outstanding academic achievements in international collaboration are eligible to be nominated for the Max Planck Research Award.

The Konrad Adenauer Research Award honors researchers from Canada whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and beyond.

To explore key questions of global importance that can best be addressed through interdisciplinary, international teams.

To support innovative, creative problem solving in cancer research.

A special initiative to allow junior investigators in cancer research to gain knowledge and understanding of the Canadian Cancer Society Research Institute peer-review process.

Focused on increasing Canada’s capacity for breast cancer prevention research. Recently appointed Assistant Postdoctoral and clinical fellows and junior faculty in the field of breast cancer, breast health, and cancer prevention are encouraged to apply.

Honours those who have contributed significantly to the scientific, cultural, and spiritual betterment of mankind.

To support innovative, creative problem solving in cancer research.

To provide funding support for clinical trials and clinical trial sub-studies that have excellent preliminary data, targeting neurodegenerative diseases of aging.

Designed for those very few instances when an exceptional research opportunity would be missed if a project had to wait to undergo the normal course of a national competition before a decision could be rendered.

Weston Brain Institute has launched a new "Big Ideas" funding program to support large scale research projects that have a significant and sustained impact on accelerating translational research on the development of therapeutics for neurodegenerative diseases of aging.

MSFHR offers match funding to qualifying BC-based researchers and research teams who are applying to non-BC government-funded research competitions that require applicants to source match funding as a condition of the application.

This Request for Applications (RFA) is designated for research to advance methods to restore, replace or provide reliable gastrointestinal and/or urodynamic function following SCI.

The Translational Research Partnership Program supports collaborative projects in cancer research to help accelerate the development of new treatments and/or technologies for the benefit of patients.

VPR Major Research Project Application Preparation grants assist SFU faculty members who are applying for major external research grants (e.g., CFI, NCE or SSHRC MCRI or INE). Assistance may take the form of support salaries for personnel needed to prepare application materials, costs of travel required to meet with research collaborators, long-distance telephone/fax charges, etc. These grants do not fund research per se.

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.

The purpose of this RFP is to solicit proposals to complete one environmental scan, a comprehensive literature review, and a knowledge synthesis and options paper that focus on respite services and support for families of CYSN (children and youth with special needs) in order to provide evidence-based advice that will support better, less fragmented services to families of CYSN in BC.

The field of sex and gender science aims to deepen our understanding of how biological and social influences interact to affect health and disease.

Genome BC’s Sector Innovation Program has launched a new intake – Intake 6 (SIP6), focusing on environmental DNA (eDNA). This competition aims to support genomics research which will address gaps in eDNA analyses that pose barriers to extract and utilize environmental information.

AstraZeneca Canada’s Corporate Giving Program seeks to improve the health and quality of life of Canadians. The company supports projects and initiatives that improve healthcare in the company's local communities, promote science education and skills among young people, support chronic disease prevention programs for adolescents, or are connected to the giving and volunteer activities of company employees.

The Canadian Hemophilia Society invites applicants to apply for basic scientific research grants in fields relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders.

The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data.

Mizutani Foundation for Glycoscience is a non-profit organization established on October 1, 1992 with funds donated by the late Mr. Masakane Mizutani, former Emeritus Chairman of Seikagaku Corporation, Tokyo, Japan. The objective of the Foundation is to promote world-wide progress in glycoscience.

The Planning Award will support teams in partnering with patients and other stakeholders to plan research studies or knowledge translation (KT) projects (knowledge dissemination or implementation) in the Fraser region.

The objective of the International stream is to support international research collaborations and position Canada and Canadian researchers as strategic partners at the international level. The New Frontiers in Research Fund (NFRF) 2020 Horizon Global Platform competition provides funding for Canadian researchers who are partners on successful projects funded through eligible calls under the EU Horizon 2020.

IC-IMPACTS is seeking project proposals in the deployment-ready stage of development related to IC-IMPACTS three themes on safe and sustainable infrastructure, integrated water management and public health and disease prevention.

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337).

This program will build teams to address challenges requiring further research and development for solutions to meet COVID-19 related needs. The NRC will build these teams drawing on internal-to-government capacity and academic researchers who register to indicate their interest, and related areas of expertise and capabilities.

Please see the following important call for project ideas or proposals from Canada's Digital Technology Supercluster for COVID-19 related-research. Further information and questions can be directed to Avi Kapoor, Strategic Partnerships Manager for SFU's Big Data Initiative.

The National Research Council is offering support, advice, and help for COVID-19 related projects in the immediate, near and medium term. Kindly see opportunity for further information.

WorkSafe BC Innovation at Work grant is designed to support small-scale one year research projects (maximum of $50,000) that lead to the development of practical solutions to address workplace health and safety issues. Please see funding opportunity for further eligiblity and application details.

Research Training Awards are designed to foster the development of occupational health and safety research expertise in B.C. These awards are available to highly-qualified graduate students at the master's and doctoral level and their purpose is to enable highly qualified students to undertake full-time research training.

The WorkSafe BC Specific Priorities/Systematic Review grants are designed to address operational need and help answer key questions in occupational health and safety and workers' compensation. These grants support short-term, primary and secondary research of immediate relevance. This research gives WorkSafe BC the strongest scientific evidence to use when developing policy and practice.

IC-IMPACTS is calling for Innovative Technology Demonstration Project proposals on an ongoing basis, relevant to one of IC-IMPACTS’ three themes of safe and sustainable infrastructure, integrated water management, and public health and disease prevention. IC-IMPACTS is especially inviting proposals within the context of the COVID-19 pandemic.

The Mitacs Globalink Research Internship is a competitive initiative for international undergraduates from the following countries and regions: Australia, Brazil, China, France, Germany, Hong Kong SAR, India, Mexico, Tunisia, United Kingdom, USA, and Ukraine. From May to October of each year, top-ranked applicants participate in a 12-week research internship under the supervision of Canadian university faculty members in a variety of academic disciplines, from science, engineering and mathematics to the humanities and social sciences.

This grant serves to establish collaboration between German universities and international partners. Applications must be submitted by German researchers. Researchers who have already achieved their doctorates and who are based at a German research institution in Germany or abroad can apply.All disciplines are eligible for the grant.

The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility. Individual Fellowships provide opportunities to researchers of any nationality to acquire and transfer new knowledge and to work on research and innovation in Europe (EU Member States and Horizon 2020 Associated Countries) and beyond. The scheme particularly supports the return and (re)integration of European researchers from outside Europe and those who have previously worked here, as well as researchers displaced by conflict outside the EU and Horizon 2020 Associated Countries. It also promotes the career restart of individual researchers who show great potential.

The Canadian Space Agency (CSA) is interested in human spaceflight and maintains a highly qualified Canadian astronaut corps capable of participating in space exploration missions. CSA has announced two new funding opportunities to provide financial support to researchers to conduct science investigations that will lead to a better understanding of human spaceflight risks while contributing to improve remote medicine and health benefits here on Earth. Please see funding opportunity link for more information.

Science magazine recognizes the achievements of researchers at all stages of their careers through a variety of prizes and awards.

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations, and are co-funded by Genome Canada, Receptors and other stakeholders.

The Diagnostics Accelerator challenges the research community to develop cutting-edge biomarkers and explore novel diagnostic technologies that will aid in Alzheimer’s diagnosis and clinical trial design. Research funded to date focuses on various methods and targets including blood tests in various stages of development, as well as eye scans and digital tools.

NSERC and the US National Science Foundation are pleased to announce the first joint collaborative research opportunity focusing on discoveries and innovations in the areas of quantum science and artificial intelligence. The work funded through this call is expected to push the boundaries of new knowledge and provide a rich training experience for young researchers. The NSERC-NSF opportunity will support collaborations between members of the research community in both countries through a flexible, streamlined application process. Through a lead agency model, U.S. and Canadian research teams will submit a single collaborative proposal that will undergo a single review process at the NSF, which will be the lead agency. Canadian academic researchers may receive funding from NSERC and U.S. researchers may receive funding from the NSF. Kindly click on the bulletin link for more information.

NSERC has announced a new, permanent funding stream called the Alliance International Grants. This new stream is to support Canadian university researchers working with leading international academic researchers to establish and grow international research collaborations and projects of global importance that will generate benefits to Canada. Alliance International offers two grant types: (1) International Catalyst grants that will provide up to $25,000 for one year to support Canadian researchers in initiating international research collaboration in the NSE disciplines and (2) International Collaboration grants that will provide up to $100,000 per year, for up to 3 years, for Canadian researchers to participate in international projects. There are no deadlines to apply and grants will awarded throughout the year. Click on the link above for more information.